Reinhart Partners Has Lowered By $1.26 Million Its Ipg Photonics Com (IPGP) Position; Capital Advisors Has Raised Its Pfizer (PFE) Stake

November 15, 2017 - By Vivian Park

Capital Advisors Inc increased Pfizer Inc (PFE) stake by 6.38% reported in 2017Q2 SEC filing. Capital Advisors Inc acquired 26,580 shares as Pfizer Inc (PFE)’s stock declined 3.45%. The Capital Advisors Inc holds 442,953 shares with $14.88M value, up from 416,373 last quarter. Pfizer Inc now has $210.89B valuation. The stock declined 0.34% or $0.12 reaching $35.26 on the news. About 153,017 shares traded. Pfizer Inc. (NYSE:PFE) has declined 2.76% since November 15, 2016 and is downtrending. It has underperformed by 19.46% the S&P500.

Reinhart Partners Inc decreased Ipg Photonics Corp Com (IPGP) stake by 42.93% reported in 2017Q2 SEC filing. Reinhart Partners Inc sold 8,665 shares as Ipg Photonics Corp Com (IPGP)’s stock rose 13.78%. The Reinhart Partners Inc holds 11,520 shares with $1.67M value, down from 20,185 last quarter. Ipg Photonics Corp Com now has $12.18B valuation. It closed at $226.27 lastly. It is down 67.64% since November 15, 2016 and is uptrending. It has outperformed by 50.94% the S&P500.

Among 12 analysts covering IPG Photonics (NASDAQ:IPGP), 7 have Buy rating, 0 Sell and 5 Hold. Therefore 58% are positive. IPG Photonics has $230.0 highest and $80 lowest target. $165.38’s average target is -26.91% below currents $226.27 stock price. IPG Photonics had 31 analyst reports since September 15, 2015 according to SRatingsIntel. On Thursday, December 10 the stock rating was initiated by Oppenheimer with “Perform”. The firm has “Buy” rating given on Monday, September 21 by DA Davidson. The stock of IPG Photonics Corporation (NASDAQ:IPGP) has “Buy” rating given on Wednesday, August 2 by Benchmark. The stock has “Outperform” rating by Credit Agricole on Friday, April 29. The stock has “Buy” rating by Needham on Friday, October 20. On Tuesday, July 18 the stock rating was downgraded by Canaccord Genuity to “Hold”. Stifel Nicolaus maintained the stock with “Hold” rating in Friday, June 30 report. The firm has “Market Perform” rating by FBR Capital given on Wednesday, May 11. The firm has “Hold” rating given on Tuesday, August 1 by Stifel Nicolaus. On Tuesday, June 6 the stock rating was upgraded by Longbow to “Buy”.

Investors sentiment decreased to 1.26 in Q2 2017. Its down 0.15, from 1.41 in 2017Q1. It dropped, as 29 investors sold IPGP shares while 108 reduced holdings. 59 funds opened positions while 114 raised stakes. 30.60 million shares or 4.09% less from 31.90 million shares in 2017Q1 were reported. Harding Loevner Lp stated it has 1.35% of its portfolio in IPG Photonics Corporation (NASDAQ:IPGP). Sg Americas Securities Ltd Com invested 0.02% of its portfolio in IPG Photonics Corporation (NASDAQ:IPGP). Cubist Systematic Strategies Ltd Liability Com invested in 0.02% or 2,427 shares. Louisiana State Employees Retirement accumulated 9,800 shares or 0.07% of the stock. Riverhead Capital Mngmt Limited Liability Company holds 0.02% of its portfolio in IPG Photonics Corporation (NASDAQ:IPGP) for 2,764 shares. Genesee Valley Tru holds 0.2% or 3,242 shares in its portfolio. Arizona State Retirement Systems reported 15,800 shares. Blair William Communication Il accumulated 3,360 shares or 0% of the stock. Huntington Savings Bank, a Ohio-based fund reported 855 shares. Susquehanna Gru Limited Liability Partnership owns 17,627 shares. Banque Pictet And Cie Sa reported 0.05% in IPG Photonics Corporation (NASDAQ:IPGP). Lord Abbett & Ltd Liability Corp owns 309,637 shares. Deutsche Bank & Trust Ag invested in 112,622 shares or 0.01% of the stock. Financial Bank Of Mellon holds 0.03% or 683,086 shares in its portfolio. Amer Century Companies has invested 0% in IPG Photonics Corporation (NASDAQ:IPGP).

Analysts await IPG Photonics Corporation (NASDAQ:IPGP) to report earnings on February, 13. They expect $1.68 earnings per share, up 20.86% or $0.29 from last year’s $1.39 per share. IPGP’s profit will be $90.43M for 33.67 P/E if the $1.68 EPS becomes a reality. After $2.11 actual earnings per share reported by IPG Photonics Corporation for the previous quarter, Wall Street now forecasts -20.38% negative EPS growth.

Reinhart Partners Inc increased Csra Inc Com stake by 114,863 shares to 732,175 valued at $23.25M in 2017Q2. It also upped Astronics Corp Com (NASDAQ:ATRO) stake by 35,600 shares and now owns 80,219 shares. Air Lease Corp Cl A (NYSE:AL) was raised too.

Since May 30, 2017, it had 0 insider buys, and 3 sales for $1.24 million activity. On Tuesday, May 30 the insider Samartsev Igor sold $280,280. SEIFERT THOMAS J sold $403,048 worth of IPG Photonics Corporation (NASDAQ:IPGP) on Monday, June 5.

Investors sentiment decreased to 0.94 in Q2 2017. Its down 0.01, from 0.95 in 2017Q1. It dropped, as 58 investors sold PFE shares while 716 reduced holdings. 112 funds opened positions while 612 raised stakes. 4.02 billion shares or 1.07% less from 4.06 billion shares in 2017Q1 were reported. Ironsides Asset Advisors Ltd invested 0.52% of its portfolio in Pfizer Inc. (NYSE:PFE). 2.27M were reported by Hightower Ltd Limited Liability Company. Plancorp Lc holds 59,695 shares. Hyman Charles D holds 0.52% or 121,233 shares in its portfolio. Cna Fincl Corp holds 186,726 shares or 1.48% of its portfolio. Cap Advsr Ok reported 442,953 shares. First Midwest Retail Bank Trust Division accumulated 104,265 shares. Wright Investors, a Connecticut-based fund reported 62,517 shares. Weatherly Asset Mngmt Lp owns 0.35% invested in Pfizer Inc. (NYSE:PFE) for 36,550 shares. Walter And Keenan Consulting Mi Adv has invested 2.17% in Pfizer Inc. (NYSE:PFE). Brown Brothers Harriman And, New York-based fund reported 327,689 shares. Amica Retiree holds 1.07% of its portfolio in Pfizer Inc. (NYSE:PFE) for 39,242 shares. Polar Limited Liability Partnership, a United Kingdom-based fund reported 1.92 million shares. Invest Management Of Virginia Lc holds 0.64% of its portfolio in Pfizer Inc. (NYSE:PFE) for 78,729 shares. Laffer Invs holds 0% or 21,714 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.